Timing of all procedures in Head dOwn-Position for acutE moderate ischaemic Stroke with large artery atherosclerosis(HOPES 3)
Timepoint | Screening | 0 | 48±12 hours | 10±2 days | 90±7 days |
Eligibility screen | x | ||||
Informed consent | x | ||||
Randomisation | x | ||||
Head CT/MRI | x* | x | |||
NIHSS assessment | x | x | x | ||
Prestroke mRS assessment | x | x | |||
Medical history | x | ||||
Population characteristics | x | ||||
Vital signs | x | x | x | x | |
TOAST classification | x | ||||
Blood routine | x | ||||
Coagulation | x | ||||
Serum biochemistry | x | ||||
ECG | x | ||||
24-hour ECG monitor | x† | ||||
Concomitant medication | x | x | x | ||
Adverse events | x | x | x | ||
Recurrent stroke and other vascular events | x | x | x |
*MRI including diffusion-weighted imaging is required either at baseline or at 48 hours.
†Performed within 10 days after admission.
mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; TOAST, Trial of Org 10 172 in Acute Stroke Treatment.